Kovina Therapeutics

Kovina Therapeutics is a preclinical drug discovery company focused on stopping human papillomavirus (HPV) premalignant infections before cancer develops and treating HPV cancers after detection. Kovina’s novel small molecule antiviral compounds bind to and inactivate a key HPV protein always expressed in early, premalignant, and cancerous pathologies.